STAB News and Press, Statera Biopharma Inc. From 04/28/22

What You Need to Know About Buying Penny Stocks Today With another day of trading penny stocks here, there is a lot for investors to consider. After an interesting day in the stock market yesterday, investors are eager to see some bullish price action return into trading today. With p...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com We’ve got plenty of earnings reports and other n...

Shares of Statera Biopharma (NASDAQ:STAB) soared 53% in aftermarket trading on Wednesday, after the company said it would sell its rights to naltrexone and met-enkephalin to Immune Therapeutics (OTCPK:IMUN). As per the deal, Statera will get an initial $2M upfront payment and 5% of ...

FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company entere...

Statera Biopharma (NASDAQ:STAB) receives Nasdaq notice as it has not yet filed its annual report for the fiscal year ended December 31, 2021. As of March 31, 2022, company was unable to file its Form 10-K within the prescribed time period due to a delay in completing its financial statem...

FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced the Company received a letter f...

The clinical-stage biotech, Checkmate Pharmaceuticals (NASDAQ:CMPI), has risen more than fourfold in value on Tuesday following its $250 million all-cash deal to be acquired by Regeneron (REGN). The announcement has propelled the developers of Toll-like receptor 9 (TLR9) agonists, a drug clas...

FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to ...

Penny stocks are a great way to make quick money, but they aren’t for the faint of heart. Whether it’s something to do with global headlines or company-specific catalysts, there are countless ways to make money with penny stocks . Knowing how to trade them and use data...

Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera Biopharma PR Newswire Entolimod is currently in clinical development as a potential treatment for acute radiation syndrome with additional pre...